PEPMAST: Innovative veterinary biopharmaceutical for sustainable bovine mastitis treatment 2026.
🐄💡 PEPMAST — an innovative veterinary biopharmaceutical for the sustainable treatment of bovine mastitis.
Based on biomimetic peptides, PEPMAST offers an effective and forward-looking approach to tackling udder infections without relying on conventional antibiotics.
This pioneering technology supports animal welfare, helps to reduce economic losses in dairy farming, lowers the risk of milk residues, and promotes more sustainable practices across the agricultural sector.
In this video, you will discover:
How PEPMAST works; Why bovine mastitis remains one of the most significant challenges in dairy production; and How this innovation contributes to animal health, the bioeconomy, and sustainability.
The PEPMAST project is coordinated by People&Science Research, Development and Innovation Ltd, based at CDT/University of Brasília (UnB), and benefits from institutional support from several national and international organisations, including The Bridge at the University of Lincoln.
The project is funded by the PEPMAST Consortium, INOVA Biomas Cerrado SEBRAE/CONFAP, FAPDF, and ICT Catalisa SEBRAE.
Instagram: @people.sciencebr
#PEPMAST #Innovation #AgriTech #AnimalHealth #Bioeconomy #Sustainability #BovineMastitis